These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


334 related items for PubMed ID: 12800576

  • 1. How the street sees biotech.
    Lashinsky A.
    Fortune; 2003 Jun 09; 147(11):86. PubMed ID: 12800576
    [No Abstract] [Full Text] [Related]

  • 2. Early-stage returns?
    Booth BL.
    Nat Biotechnol; 2006 Nov 09; 24(11):1335-40. PubMed ID: 17093473
    [Abstract] [Full Text] [Related]

  • 3. Biotech bonanza.
    Stipp D.
    Fortune; 1999 Nov 08; 140(9):333-4. PubMed ID: 10623111
    [No Abstract] [Full Text] [Related]

  • 4. Nasdaq restructures biotech index.
    Morrison C.
    Nat Biotechnol; 2001 Mar 08; 19(3):187. PubMed ID: 11231518
    [No Abstract] [Full Text] [Related]

  • 5. Little biotech on the prairie.
    Wolfson W.
    Chem Biol; 2007 Sep 08; 14(9):969-71. PubMed ID: 17884626
    [No Abstract] [Full Text] [Related]

  • 6. Biotech slumps in Q1.
    Lawrence S.
    Nat Biotechnol; 2008 May 08; 26(5):486. PubMed ID: 18464769
    [No Abstract] [Full Text] [Related]

  • 7. Public biotech 98: the numbers.
    Lähteenmäki R, Michael A, Marshall A.
    Nat Biotechnol; 1999 May 08; 17(5):429-32. PubMed ID: 10331795
    [No Abstract] [Full Text] [Related]

  • 8. Spinning the wheel on ImClone.
    Varchaver N.
    Fortune; 2003 Apr 28; 147(8):123-5. PubMed ID: 12728651
    [No Abstract] [Full Text] [Related]

  • 9. Eli Lilly enters venture capital arena.
    Fletcher L.
    Nat Biotechnol; 2001 Nov 28; 19(11):997-8. PubMed ID: 11689830
    [No Abstract] [Full Text] [Related]

  • 10. Any diamonds in the diagnostic coal?
    Jacobs T.
    Nat Biotechnol; 2006 Aug 28; 24(8):930. PubMed ID: 16900133
    [No Abstract] [Full Text] [Related]

  • 11. Biotech's wonder ride.
    Rynecki D.
    Fortune; 2000 Mar 06; 141(5):435-6. PubMed ID: 10788046
    [No Abstract] [Full Text] [Related]

  • 12. A special biotech speculation.
    Jacobs T.
    Nat Biotechnol; 2006 Jun 06; 24(6):622. PubMed ID: 16763586
    [No Abstract] [Full Text] [Related]

  • 13. Bugs or drugs, tortoises or hares?
    Jacobs T.
    Nat Biotechnol; 2005 Mar 06; 23(3):293. PubMed ID: 15765079
    [No Abstract] [Full Text] [Related]

  • 14. The stampede to convertibles.
    Jacobs T.
    Nat Biotechnol; 2003 Aug 06; 21(8):855. PubMed ID: 12894195
    [No Abstract] [Full Text] [Related]

  • 15. Biotechs hold their own in shifting industry.
    Mitchell P.
    Nat Biotechnol; 2002 Nov 06; 20(11):1065-6. PubMed ID: 12410238
    [No Abstract] [Full Text] [Related]

  • 16. Investment indicators show US is still ahead.
    Lähteenmäki R, Hodgson J.
    Nat Biotechnol; 1998 Feb 06; 16(2):149-50. PubMed ID: 9487519
    [No Abstract] [Full Text] [Related]

  • 17. Shutters come off IPO window.
    Hodgson J.
    Nat Biotechnol; 2002 Jan 06; 20(1):6. PubMed ID: 11753342
    [No Abstract] [Full Text] [Related]

  • 18. Biotech meets the investors.
    Berry S.
    Trends Biotechnol; 2002 Sep 06; 20(9):370-1. PubMed ID: 12175762
    [No Abstract] [Full Text] [Related]

  • 19. Japanese firms broaden investment focus to early biotech.
    Louët S, Sipp D.
    Nat Biotechnol; 2004 Aug 06; 22(8):931-2. PubMed ID: 15286631
    [No Abstract] [Full Text] [Related]

  • 20. Healthcare stocks soar on wings of restructuring.
    Lutz S.
    Mod Healthc; 1996 Jan 08; 26(2):3. PubMed ID: 10153952
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.